Stay updated with breaking news from Chandra pharmalab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ChrysCap to buy 30% in Corona Remedies for Rs 670 crore SECTIONS Share Synopsis ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days. Reuters Homegrown private equity fund ChrysCapital will invest about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies. ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days. ....